BIRC6 is among the apoptosis inhibitors, and prior studies have investigated its role in various cancers, proposing that BIRC6 has the capability to degrade pro-apoptotic proteins [ 21- 22] and deregulate extrinsic and intrinsic cell death pathways [ 23- 24]. Here, BIRC6 is linked to cancer.